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Abstract: An octapeptide containing a central OAib–Gly– segment capable of adopting b-turn
conformations compatible with both hairpin (bII9 or bI9) and helical (bI) structures has been
designed. The effect of solvent on the conformation of the peptide Boc–Leu–Val–Val–Aib–Gly–Leu–
Val–Val–OMe (VIII; Boc: t-butyloxycarbonyl; OMe: methyl ester) has been investigated by NMR
and CD spectroscopy. Peptide VIII adopts a well-defined b-hairpin conformation in solvents
capable of hydrogen bonding like (CD3)2SO and CD3OH. In solvents that have a lower tendency to
interact with backbone peptide groups, like CDCl3 and CD3CN, helical conformations predominate.
Nuclear Overhauser effects between the backbone protons and solvent shielding of NH groups
involved in cross-strand hydrogen bonding, backbone chemical shifts, and vicinal coupling con-
stants provide further support for the conformational assignments in different solvents. Truncated
peptides Boc–Val–Val–Aib–Gly–Leu–Val–Val–OMe (VII), Boc–Val–Val–Aib–Gly–Leu–Val–OMe
(VI), and Boc–Val–Aib–Gly–Leu–OMe (IV) were studied in CDCl3 and (CD3)2SO by 500 MHz
1H-NMR spectroscopy. Peptides IV and VI show no evidence for hairpin conformation in both the
solvents. The three truncated peptides show a well-defined helical conformation in CDCl3. In
(CD3)2SO, peptide VII adopts a b-hairpin conformation. The results establish that peptides may be
designed, which are poised to undergo a dramatic conformational transition. © 2001 John Wiley
& Sons, Inc. Biopolymers 58: 465–476, 2001
Keywords: b-hairpin; helix; conformational transition; truncated peptides; nuclear Overhauser
effects; backbone chemical shifts
INTRODUCTION
Conformations of polypeptide chains are determined
by subtle sequence and environmental effects. The
a-helix and b-sheet are the two major elements of
secondary structure, which have been widely studied
in proteins1–3 and synthetic peptides and polypep-
tides.4–6 Conformational transitions between these
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two ordered states of polypeptide chains were initially
observed in studies of synthetic homopolypeptides.7,8
Subsequently, studies of helix to sheet transitions
have acquired a new dimension because of the impor-
tance of such conformational changes in pathological
conditions involving prion proteins9,10 and Alzhei-
mer’s disease.11 Several recent investigations have
focused on helix to sheet interconversions in model
synthetic peptides.12–20 Most studies have been car-
ried out using amphiphilic sequences in aqueous sol-
vents.12,13 Alteration in pH,14–16 temperature,17 salt
or organic cosolvent concentration14,16,18 or redox
state19,20 have been used to initiate the structural
transition, presumably by modulation of several dis-
tinct interactions involving both the polypeptide back-
bone and amino acid side chains.
We have been interested in designing an apolar
peptide with a tendency to populate both well-defined
helical and b-hairpin conformations, which would
permit studies of conformational interconversion by
varying the nature of organic solvent media. Struc-
tural transitions would be governed predominantly by
the hydrogen-bonding ability of the solvent. We de-
scribe in this report conformational analysis of an
apolar octapeptide Boc–Leu–Val–Val–Aib–Gly–
Leu–Val–Val–OMe (VIII), which demonstrates sol-
vent dependent conformational variability. The
conformational analysis of the truncated peptides,
Boc–Val–Val–Aib–Gly–Leu–Val–Val–OMe (VII),
Boc–Val–Val–Aib–Gly–Leu–Val–OMe (VI), and
Boc–Val–Aib–Gly–Leu–OMe (IV) were also studied
(peptide numbers correspond to the number of resi-
dues). Evidence is presented for both helical and
b-hairpin conformations.
EXPERIMENTAL PROCEDURE
Materials and Methods
Peptides were synthesized by classical solution phase pro-
cedures using a fragment condensation strategy described
earlier.21 The t-butyloxycarbonyl (Boc) group was used for
N-terminal protection and the C-terminal was protected as a
methyl ester (OMe). Deprotection was achieved with 98%
formic acid or 2N NaOH/MeOH, respectively. Couplings
were mediated by dicyclohexylcarbodiimide/1-hydroxyben-
zotriazole. All intermediates were characterized by 1H-nmr
(80 MHz) and thin layer chromatography on silica gel.
These intermediates were used without further purification.
Peptides were purified by medium pressure liquid chroma-
tography on a C-18 (40–60 m) column using methanol–
water gradients. Peptides IV, VI, VII, and VIII were purified
by high performance liquid chromatography on reverse
phase (RP-HPLC) C-18 (10 m) column using methanol–
water gradients. The peptides were checked for homogene-
ity by analytical RP-HPLC (C-18, 250 3 4.6 mm, 5 m) with
a gradient of 60–95% aqueous methanol in 30 min; detec-
tion 226 nm, flow rate 0.8mL/min. Retention times (tR min)
were compared for the peptides under identical conditions.
The peptides were characterized by complete assignment of
1H-NMR spectra recorded on a Bruker DRX-500 MHz
spectrometer and by electrospray mass spectrometry. The
mass spectra were recorded on a HP 1100 electrospray
ionization–mass spectroscopy (ESI-MS), interfaced with an
HPLC. Data in the positive ion mode were acquired in the
scan mode in the range of 200–1000 Da. Peptides were
infused into the electrospray chamber in methanol solution
using a flow of 0.04 mL/min.
Physical Data for Peptides VIII, VII,
VI, and IV
Boc–Leu–Val–Val–Aib–Gly–Leu–Val–Val–OMe
(VIII). Melting point 116–118°C, tR 20.8 min, ESI-MS:
(calc. mass 896.6) 919([M1Na]1), 897([M11]1).
Boc–Val–Val–Aib–Gly–Leu–Val–Val–OMe (VII).
Melting point 120–122°C, tR 17.8 min, ESI-MS: (calc.
mass 783.5) 806([M1Na]1), 784([M11]1).
Boc–Val–Val–Aib–Gly–Leu–Val–OMe (VI). Melting
point 113–114°C, tR 14.3 min, ESI-MS: (calc. mass 684.4)
707([M1Na]1), 685([M11]1).
Boc–Val–Aib–Gly–Leu–OMe (IV). Melting point 101–
103°C, tR 12.1 min, ESI-MS: (calc. mass 486.3)
509([M1Na]1), 487([M11]1).
NMR and CD
Resonance assignments were done using rotating frame
nuclear Overhauser effect spectroscopy (ROESY) spectra.
All two-dimensional experiments were recorded in phase
sensitive mode by using the time proportional phase incre-
mentation method. The amount of 1024 and 512 data points
were used in the t2 and t1 dimensions, respectively. The
resultant data set was zero filled to finally yield 1K 3 1K
data points. A shifted square sine bell window was used in
both dimensions. Spectral widths were in the range of 4500
Hz. Peptide concentrations were ;7 mM in CDCl3,
(CD3)2SO, and CD3OH and 3 mM in CD3CN. The probe
temperature was maintained at 298K. CD spectra were
recorded on JASCO J-500 spectropolarimeter using 1 mm
path-length cells. Each spectrum is the resultant of four
scans. Band intensities are reported as molar ellipticities,
[u]M (deg cm2 decimol21).
RESULTS AND DISCUSSION
Design
Peptide VIII was designed on the basis of earlier
studies of peptide in this laboratory, which established
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a b-hairpin conformation for the peptide Boc–Leu–
Val–Val–D-Pro–Gly–Leu–Val–Val–OMe (BH8) in
solution22,23 and in crystals24 (Figure 1). In peptide
BH8, the D-Pro–Gly segment adopts a type II9 b-turn
conformation, as a consequence of the restriction of f
D-Pro to a value ; 160° 6 20°. The type II9 b-turn
serves as a nucleus for a hairpin conformation, which
is further facilitated by the incorporation of the
b-branched residue, valine, in the potential strand
segment.25,26 In peptide VIII, the D-Pro residue is
replaced by Aib. Extensive stereochemical studies on
achiral Aib residues have established a strong ten-
dency to adopt either right-handed or left-handed (f
5 60° 6 20°, c 5 30° 6 20°) helical conforma-
tions.27–32 In addition, theoretical calculations show
the presence of minima in a semiextended region of
f,c space (f 5 660° 6 20°, c 5 6120° 6 20).27
In peptide VIII, if Aib(4) adopts an aL conforma-
tion, the Aib–Gly segment could adopt, in principle, a
type I9 b-turn structure (f Aib ; f Gly ; 160°, c
Aib ; c Gly ; 130°) capable of nucleating a b-hair-
pin. If Aib(4) adopts a semiextended conformation (f
; 6 60°, c ; 1120°), the Aib–Gly segment can
adopt a type II9 conformation analogous to peptide
BH8.22–24 However, it should be noted that the
semiextended conformation is quite uncommon for
Aib residues that are in an internal position in a
peptide. A rare example of a type II9 Aib–Ala b-turn,
with a semiextended Aib conformation has been ob-
served in crystals of a cyclic hexapeptide having a
disulfide linkage.33 If Aib(4) adopts a right-handed
helical conformation (aR , f ; 660° , c ; 630°),
then nucleation of a 310/a-helix over the entire length
of sequence is possible. Indeed, several examples
exist in the literature in which a single, centrally
placed Aib residue nucleates a 310/a-helical confor-
mation in peptides of length 7–8 residues.27–31,34–36
The sequence of peptide VIII is set up to undergo
conformational changes, with the Aib–Gly segment
acting as a nucleus capable of adopting distinct con-
formational states. Figure 2 schematically illustrates
FIGURE 1 Schematic diagram of a two-residue loop
b-hairpin conformation for octapeptides BH8 (left) and
VIII (right) respectively. U: Aib.
FIGURE 2 Schematic representation of intramolecular hydrogen bond patterns in ideal 310-
helical and b-hairpin conformations.
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the nature of intramolecular hydrogen-bond patterns
anticipated in ideal 310-helical and b-hairpin confor-
mations of the protected octapeptide. In the 310-helix,
6 intramolecular hydrogen bonds are possible, while
in the b-hairpin a maximum of four intramolecular
hydrogen bonds are possible. Clearly, if there are no
overwhelming preferences for specific local backbone
conformation at individual residues (barring Aib) then
overall peptide conformation may indeed be driven by
the balance between intrapeptide and solvent-peptide
hydrogen bonds. Consideration of a 310-helix is rea-
sonable because many small Aib-containing peptides
do indeed adopt 310-helical folds.27,34,37–39 Further-
more, even in cases where mixed 310 /a-helical struc-
tures are observed, the initial turn at the N-terminus
accommodates both 4 3 1 and 5 3 1 hydrogen
bonds, resulting in only two non hydrogen-bonded
NH groups at the amino terminus end.34
Circular Dichroism
Figure 3a shows the CD spectra of VIII in methanol
and acetonitrile. Two distinct bands at 204 and 219
nm are observed in acetonitrile, characteristic of a
significant population of helical conformations. The
CD spectra resemble those observed earlier for short
helical peptides in organic solvents.40,41 In sharp con-
trast, in methanol, a single negative band at 215 nm,
is observed, a feature that has also been noticed in
several short peptides adopting a b-hairpin conforma-
tion.22,23,42–45 The solvent dependence of CD spectra
suggests that conformer populations are biased in
favor of helical structures in a solvent like acetoni-
trile, which has a limited ability to hydrogen bond
with peptides, since it is capable of acting as a hydro-
gen acceptor. In methanol, which can, in principle, act
as both hydrogen donor and acceptor, b-hairpin con-
formations appear to predominate. Based on these
observations, detailed NMR studies were undertaken
in four solvents CDCl3, CD3CN, CD3OH, and
(CD3)2SO. CD spectra of truncated peptides VII, VI,
and IV are shown in Figure 3b. Despite loss of
Leu(1), the CD spectrum of peptide VII in methanol
shows evidence for the presence of a significant pop-
ulation of b-hairpin conformers. Further truncation of
the sequence results in a loss of ellipticity at 215 nm.
Nuclear magnetic resonance analysis of shorter pep-
tides (vide infra) reveals no evidence for putative
hairpin conformations.
NMR Analysis
Peptide VIII exhibited sharp well-resolved 500 MHz
1H-NMR spectra in all four solvents. Complete reso-
nance assignments were readily achieved using
ROESY spectra and specific features of one-dimen-
sional (1D) spectra—viz. multiplicity of Aib (singlet)
and Gly (triplet) NH resonances that facilitate unam-
biguous assignments. The chemical shifts of the back-
bone NH and CaH protons in the four solvents are
summarized in Figure 4. Chemical shifts of CaH and
NH protons are a very sensitive indicator of backbone
conformation in polypeptides.46–48 It is readily appar-
ent from Figure 4 that the chemical shift patterns
observed in CDCl3 and CD3OH are distinctly differ-
ent. In CDCl3, all NH protons appear distinctly up-
field relative to the positions in CD3OH. The CaH
protons show a significantly larger chemical shift
dispersion in CD3OH as compared to CDCl3. The
FIGURE 3 CD spectra of peptides VIII, VII, VI, and IV.
(a) Peptide VIII in methanol () and in acetonitrile (E). (b)
Peptides VII, VI, and IV in methanol. Concentration of the
peptides: ;2.7 3 1024 mmol.
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solvent dependence of chemical shifts, particularly of
CaH protons, which do not interact strongly with a
hydrogen-bonding solvent, is a clear indicator of
shifting conformer populations. Nuclear Overhauser
effects49 that are of specific importance in conforma-
tional assignments are summarized in Table I.
Conformations in (CD3)2SO
In (CD3)2SO, a strong NOE is observed between
Val(2)CaH 7 Val(7)CaH, clearly diagnostic of a
b-hairpin structure (Figure 5). The presence of strong
sequential CaiH 7 Ni11H NOEs from Leu(1) to
Aib(4) and Gly(5) to Val(8) and absence of sequential
NH 7 NH connectivity over the segment Val(2)
7 Val(8) (Figure 6) support a major population of
b-hairpins. The large 3JNH-CaH values for the Leu(1)
7 Val(3) [Leu(1) 9.1 Hz, Val(2) 9.6 Hz, Val(3) 8.2
Hz] segment also support the b-strand conformation,
although somewhat lower values are detected for the
C-terminus [Leu(6) 5.6 Hz, Val(7) 7.1 Hz, Val(8) 7.8
Hz]. The pattern of CaH and NH chemical shifts for
peptide VIII in (CD3)2SO closely parallels that ob-
served for the parent b-hairpin model BH8, which
contains D-Pro in place of Aib(4).
Conformations in CD3OH
From Table I, two key long-range NH 7 NH NOEs
Leu(1) 7 Val(8) and Val(3) 7 Leu(6) are evident.
These cross-strand NOEs provide clear evidence for
an appreciable population of b-hairpins. The rela-
FIGURE 4 Schematic representation of NH and CaH chemical shifts for peptide VIII in CDCl3,
CD3CN, (CD3)2SO, and CD3OH.
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tively intense CiaH 7 Ni11H NOEs are also consis-
tent with extended conformations for the Leu(1) to
Val(3) and Leu(6) to Val(8) segments. Large 3JNH-CaH
coupling constant (.8 Hz) are also observed for the
residues in the strand segment, with the exception of
Val(2). Cross strand Val(2) CaH 7 Val(7) CaH
NOEs are not observed because of overlap and inter-
ference from the residual OH signal in CD3OH. The
Aib(4) 7 Gly(5) and Gly(5) 7 Leu(6) Ni H(Ni11H
NOEs are consistent with a local helical conformation
at Aib(4) and Gly(5), suggestive of a type I9 b-turn
structure at this segment [Aib(4) f 5 60°, c5 30°;
Gly(5) f 5 90°, c 5 0°]. The absence of detectable
sequential NH7 NH NOEs in the Val(2)7 Aib(4)
and Val(7) 7 Val(8) segments is indicative of an
absence of a significant population of continuous
helical conformations. The observation of the se-
quential NH 7 NH NOEs between Leu(1) 7
Val(2) and Leu(6) 7 Val(7) does suggest, how-
ever, that there is conformational heterogeneity in
solution, with the possibility of structures in which
Leu(1) and Leu(6) lie in the helical region of f,c
space. The body of NMR evidence favors a pre-
dominance of b-hairpin conformations in CD3OH,
consistent with the conclusions drawn from the CD
spectra in Figure 3a.
Table I Summary of NOEs for the Peptides in CDCl3 and (CD3)2SO
Summary of NOEsa
NH7NH CaH 7 NH
Conformational
Conclusions
CDCl3 DMSO CDCl3 DMSO CDCl3 DMSO
Peptide VIII
L(1) 7 V(2) w (s) m [s] s (s) s [m]
V(2) 7 V(3) w (w) — [—] m (s) s [m] Helix Hairpin
V(3) 7 U(4) — (m) — — (s) s [m] (major) (major)
U(4) 7 G(5) — (m) — [s] — (—) — [—]
G(5) 7 L(6) s (s) — [m] w (w) s [m] Hairpin Helix
L(6) 7 V(7) s (s) — [m] s (s) s [s] (minor) (minor)
V(7) 7 V(8) m (m) — [—] s (s) s [s]
CaH 7 CaH NOEs
V(2) 7 V(7) m (m) s
L(1) 7 V(8) — (w) — [w]
V(3) 7 L(6) — (w) [s]
Peptide VII
V(1) 7 V(2) w w s s
V(1) 7 U(3) w w s s Helix Hairpin
U(3) 7 G(4) m m — — (major) (major)
G(4) 7 L(5) s — w s
L(5) 7 V(6) s w s s
V(6) 7 V(7) m — s s
CaH 7 CaH NOEs
V(1) 7 V(6) — m
Peptide VI
V(1) 7 V(2) s s m m
V(2) 7 U(3) s s m m
U(3) 7 G(4) m s — — Helix Helix
G(4) 7 L(5) m m w m
L(5) 7 V(6) m s m m
Peptide IV
V(1) 7 U(2) w m s m
U(2) 7 G(3) s — — — Turn Turn
G(3) 7 L(4) m — m s
V(1) 7 L(4) — w
a NOEs of peptide VIII in CD3CN and CD3OH are given in parentheses and square brackets, respectively. NOE intensities are abbreviated
as s 5 strong; m 5 medium; w 5 weak; — indicates that no NOE was detectable under the conditions used.
470 Awasthi et al.
Conformations in CDCl3
In this solvent, the pattern of NOEs (Table I) is
suggestive of population of both helical and b-hairpin
conformations, although sequential NiH 7 Ni11H
NOEs are not observed (Figures 7 and 8) over the
entire peptide length. The comparison of chemical
shifts observed for peptide VIII with the parent
b-hairpin BH8 reveals several important differences.
The much smaller dispersion of both NH and CaH
chemical shifts in peptide VIII suggests that b-hairpin
conformations are only minor contributors to the con-
formational equilibrium. The largest chemical shift
difference between VIII and BH8 are observed for
Val(3) NH (1.26 ppm), Gly(5) NH (1.25 ppm), Val(8)
NH (1.11 ppm), Val(2) CaH (0.64 ppm), Val(3) CaH
(0.64 ppm). The observed 3JNCHaH values at Val(2),
Val(3), and Leu(6) are also much lower [Val(2) 4.7
Hz, Val(3) 4.9 Hz, and Leu(6) 6.9 Hz] , characteristic
of helical conformations.
Addition of the free radical 2,2,6,6 tetramethylpi-
peridine-1-oxyl50,51 (TEMPO) resulted in selective
broadening of Leu(1) and to some extent Val(2) NH,
while the remaining NH resonances were largely un-
affected up to a radical concentration of 11.4
3 1024M (data not shown). This suggests greater
solvent exposure of Leu(1) and Val(2) NH, a feature
suggestive of a predominantly 310 -helical conforma-
tion.
Conformations in CD3CN
In this solvent three cross-strand NOEs diagnostic of
b-hairpin conformations are observed—viz. Leu(1)
NH 7 Val(8) NH, Val(3) NH 7 Leu(6) NH, and
Val(2) CaH 7 Val(7) CaH (Table I) . Of these, the
two long- range NH 7 NH NOEs are very weak in
intensity, suggestive of a relatively low population of
folded hairpins. In contrast, to the results in CD3OH
and (CD3)2SO sequential NiH7 Ni11H are observed
over the entire length of the peptide, strongly suggest-
ing an appreciable population of helical conforma-
tions. The 3JNCHaH values for the Leu(1) to Val(3)
FIGURE 5 Partial ROESY spectrum of the peptide VIII in (CD3)2SO highlighting CaH7 CaH
cross strand NOEs.
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segment [Leu(1) 6.3 Hz, Val(2) 8.5 Hz, Val(3) 7.0
Hz] are also appreciably lower than that determined in
(CD3)2SO. The nmr data thus favors a major popula-
tion of helical conformations in CD3CN, consistent
with the CD results (Figure 3a).
NMR Analysis of Truncated Peptides
Sequence-specific assignments in CDCl3 and (CD3)2SO
were readily achieved for peptides VII, VI, and IV. The
key interresidue NOEs between backbone protons are
FIGURE 6 Partial ROESY spectra of peptide VIII in (CD3)2SO. The top panel shows CaH
7 NH NOEs, and the lower panel shows NH 7 NH NOEs. Assignments are marked on the 1D
spectra.
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summarized in Table I. Interstrand NOEs characteristic
of a population of b-hairpin conformations were ob-
served only for peptide VII in (CD3)2SO. Figure 9
shows the ROESY spectra of peptide VII, illustrating
the observed NOE between Val(1)CaH–Val(6)CaH. In
all three truncated peptides, sequential NH—NH NOEs
characteristic of local helical conformations are ob-
served. The inference that largely helical conformations
are favored in CDCl3 for peptides VII, VI, and IV is
consistent with the observed NOE results. The delinea-
tion of intramolecularly hydrogen-bonded NH groups in
peptides VII, VI, and IV was achieved using solvent
titration of NH chemical shifts in CDCl3–(CD3)2SO
mixtures and free radical (TEMPO) induced broadening
in CDCl3. In all the three peptides, clear evidence was
obtained for the solvent exposure of NH groups of
residues 1 and 2 only (data not shown). These observa-
tions, together with the known tendency of Aib residues
to promote helical folding in peptides, argue for a pre-
ponderance of helical conformations in peptides VII,
VI, and IV in CDCl3. Further support for this conclusion
is obtained from the crystal structure of peptide IV,
which reveals an incipient 310-helical conformation in-
volving Gly(3)NH and Leu(4)NH in intramolecular hy-
FIGURE 7 Partial ROESY spectra of peptide VIII in CDCl3. The top panel shows CaH 7 NH
NOEs, and the lower panel shows NH 7 NH NOEs. Assignments are marked on the 1D spectra.
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drogen bonds (N. Shamala, personal communication). In
(CD3)2SO, helical conformations appear to persist in the
case of peptides IV and VI, with no evidence obtained
for short hairpin structures. However, in peptide VII,
b-hairpin conformations make a significant contribution
to the conformational equilibrium, as evidenced by the
intense Val(1)CaH–Val(6)CaH NOE.
CONCLUSIONS
The NMR and CD results presented in this paper
suggest that the octapeptide Boc–Leu–Val–Val–Aib–
Gly–Leu–Val–Val–OMe (VIII) is poised to undergo
a solvent-dependent conformational transition be-
tween b-hairpin and 310-helical structures. In solvents
capable of hydrogen bonding like (CD3)2SO and
CD3OH, b-hairpins are favored. In the b-hairpin con-
formation, solvation of the CO and NH groups that
face outward from the strand segments and the central
peptide group in the b-turn is favored in solvents that
can form hydrogen bonds. In particular, in methanol,
both donor and acceptor interactions are possible,
facilitating peptide bond solvation. In solvents that
have a lower tendency to interact with backbone pep-
tide groups, helical conformations are predominant.
The balance between inter- and intramolecular hydro-
gen bonds determines the conformational distribution.
In the present study, we have preferred to make an
assignment of a 310-helical conformational in CDCl3
based upon the observation of only two solvent-ex-
posed NH groups in the nmr studies. In short peptides,
with relatively low Aib content, a-helical conforma-
tions also have been observed in the solid state.28–31
We have deliberately underemphasized the precise
nature of the helical conformation since 310/a-helical
and mixed helical structures can all be broadly
grouped into one conformational family of peptide
helices with very small barriers to interconversion
amongst themselves.52 The purpose of the present
study is really to explore conformational interconver-
FIGURE 8 Partial ROESY spectrum of peptide VIII in CDCl3 , highlighting CaH 7 CaH
cross-strand NOEs.
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sion between families of the b-hairpin conformation
on one hand and helices on the other.
The observation of sharp nmr resonances in all four
solvents indicates that the rates of interconversion are
fast on the nmr time scale. However, a low temperature
study may indeed permit determination of activation
barriers for such processes. Studies on truncated se-
quences suggest that chain length has a major influence
on the equilibrium between b-hairpin and helical struc-
tures. In the shorter peptides, helices appear to predom-
inate, while in the 7 and 8 residue peptides b-hairpins are
populated under favorable solvent conditions. This study
also illustrates the possibility of selectively using Aib
residues to nucleate isolated turns in the context of
non-helical structures, resulting in stabilization of
b-hairpins in an acyclic peptide. An earlier example of a
b-hairpin containing a Aib residue in the turn segment
involved covalent cross-linking of antiparallel strands
through disulfide linkages.33 Several recent studies em-
ploy D-Pro–Xxx and Asn–Gly segments for nucleation
of the b-hairpin conformations (see Ref. 29 and refer-
ences cited therein). Our present study suggest that cen-
trally positioned Aib–Gly segments may also serve to
nucleate b-hairpins although these sequences may be
more prone to conformational changes upon varying
solvent composition. The use of D-residues in place of
Gly may be an effective way of stabilizing hairpins over
right-handed helical conformations.
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